News & Events
News & Events
Enrollment Open for 2017 Spring Semester UST-IPK Ph.D. Course
2016-09-01
Pangyo, Gyeonggi, 1 Sept, 2016 | Institut Pasteur Korea announces open enrollment for the University of Science and Technology (UST) - Institut Pasteur Korea (IPK) 2017 Spring semester Ph.D. course (Major: Biological Chemistry). From 1 Sept, 2016 ~ 28 Sept, 2016, graduate students interested in infectious disease research and drug discovery can enroll in for the Spring semester. The Ph.D. course is a hands-on, on-site R&D education program engineered for graduate students to gain practical experience working with international scientists from the Institut Pasteur International Network
Founded in 2004, UST aims to foster highly qualified R&D professionals in the field of new convergence technology through on-site R&D education. IPK became a member campus in 2014 and is the only non-profit research organization on the 33 member campus roster.
Space is limited; 4 graduate students for special admission and 4 graduate students for general admission will be allowed to participate, so early registration is encouraged. (Special admission: 1 Sept ~ 28 Sept, General admission: 19 Sept ~ 28 Sept) For more detailed information on the UST course, please visit http://www.ust.ac.kr. To learn more about IPK, please go to http://www.ip-korea.org/about_us/overview.php or contact us at t: 031-8018-8041, e: publicaffairs@ip-korea.org.
# # # # # #
About Institut Pasteur Korea
Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and an economic growth engine that contributes to Korea’s scientific intellectual and technical resources. IPK has four core missions of public interest – 1) Research, combining front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases, 2) Education, offering a wide range of programming to nurture the development of the next generation of scientists and health professionals, 3) Public Health, working in collaboration with national and international health authorities, and 4) Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
IPK is a member of the Institut Pasteur International Network (Network). As a hub intuition, IPK plays a key role in the Network, serving as a bridge between Korea and global bio-pharma science, expanding Korea’s R&D base collaborative research projects with global alliances
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science, ICT and Future Planning (MSIP). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).
Founded in 2004, UST aims to foster highly qualified R&D professionals in the field of new convergence technology through on-site R&D education. IPK became a member campus in 2014 and is the only non-profit research organization on the 33 member campus roster.
Space is limited; 4 graduate students for special admission and 4 graduate students for general admission will be allowed to participate, so early registration is encouraged. (Special admission: 1 Sept ~ 28 Sept, General admission: 19 Sept ~ 28 Sept) For more detailed information on the UST course, please visit http://www.ust.ac.kr. To learn more about IPK, please go to http://www.ip-korea.org/about_us/overview.php or contact us at t: 031-8018-8041, e: publicaffairs@ip-korea.org.
# # # # # #
About Institut Pasteur Korea
Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and an economic growth engine that contributes to Korea’s scientific intellectual and technical resources. IPK has four core missions of public interest – 1) Research, combining front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases, 2) Education, offering a wide range of programming to nurture the development of the next generation of scientists and health professionals, 3) Public Health, working in collaboration with national and international health authorities, and 4) Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
IPK is a member of the Institut Pasteur International Network (Network). As a hub intuition, IPK plays a key role in the Network, serving as a bridge between Korea and global bio-pharma science, expanding Korea’s R&D base collaborative research projects with global alliances
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science, ICT and Future Planning (MSIP). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).